PRRT (Peptide Receptor Radionuclide Therapy) is a treatment used for neuroendocrine tumors (NETs). This treatment uses a radiopeptide which is a medication called octreotide (a type of peptide or protein) and a small amount of a radioactive material (called a radionuclide).
Most NETs have receptors on their cells for a hormone called somatostatin. Octreotide is a manmade version of somatostatin, which is attracted to these receptors on the NETs. In PRRT, the octreotide has a radionuclide attached to it. This lets the octreotide bring the radiation right to the tumor, and not to healthy tissues. This targeted therapy limits the radiation exposure to healthy tissue and often has fewer side effects than chemotherapy medications. Lutetium 177 (Lu-177) is the most used radionuclide.
Tell your healthcare team if you are pregnant or plan to become pregnant, as radionuclides can be harmful to an unborn baby.
This depends on the center doing your treatment and the radionuclide being used. PRRT is usually given in four treatments every two months over eight months. The steps of treatment are:
Whether or not you stay overnight in the hospital depends on the local regulations/laws and which radionuclide was used.
Some radiation stays in your body for a few days, and you will be taught how to keep family members safe at home. You may be told to:
Your care team will talk with you and your caregivers about any special precautions you might need to take.
The most common side effects of PRRT are:
Talk to your provider about your side effects. Most side effects can be managed. Your blood counts and labs will be monitored to see how your body is responding to the treatment.
What Is Peptide Receptor Radionuclide Therapy (PRRT)? Fact sheet from the Society of Nuclear Medicine and Molecular Imaging
OncoLink is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem or have questions or concerns about the medication that you have been prescribed, you should consult your health care provider.
Information Provided By: www.oncolink.org | © 2025 Trustees of The University of Pennsylvania